Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C S Rock

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Surgical Research|November 1, 1991
Tumor necrosis factor-alphaC S Rock, S F Lowry
Annals of Plastic Surgery|September 1, 1996
Aesthetic breast reconstruction using a combination of free transverse rectus abdominis musculocutaneous flaps and breast implantsM J Miller, C S Rock, G L Robb
Infection and Immunity|July 1, 1992
In vivo effects of the antiglucocorticoid RU 486 on glucocorticoid and cytokine responses to Escherichia coli endotoxinA S Hawes, C S Rock, C V Keogh, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1992
Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivoK J Van Zee, T Kohno, E Fischer, et al.
The American Journal of Physiology|March 1, 1992
Insulin-like growth factor I preserves host lean tissue mass in cancer cachexiaE H Ng, C S Rock, D D Lazarus, et al.
The Journal of Surgical Research|August 1, 1991
Impact of exogenous growth hormone on host preservation and tumor cell-cycle distribution in a rat sarcoma modelE H Ng, C S Rock, D Lazarus, et al.
Annals of Surgery|July 1, 1993
Comparison of peripheral blood leukocyte kinetics after live Escherichia coli, endotoxin, or interleukin-1 alpha administration. Studies using a novel interleukin-1 receptor antagonistA S Hawes, E Fischer, M A Marano, et al.
Surgery|August 1, 1992
Influence of hypercortisolemia on the acute-phase protein response to endotoxin in humansC S Rock, S M Coyle, C V Keogh, et al.
Blood|May 1, 1992
Interleukin-1 receptor antagonist circulates in experimental inflammation and in human diseaseE Fischer, K J Van Zee, M A Marano, et al.
The American Journal of Physiology|August 1, 1991
Comparison between effects of interleukin-1 alpha administration and sublethal endotoxemia in primatesE Fischer, M A Marano, A E Barber, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Surgical Research|November 1, 1991
Tumor necrosis factor-alphaC S Rock, S F Lowry
Annals of Plastic Surgery|September 1, 1996
Aesthetic breast reconstruction using a combination of free transverse rectus abdominis musculocutaneous flaps and breast implantsM J Miller, C S Rock, G L Robb
Infection and Immunity|July 1, 1992
In vivo effects of the antiglucocorticoid RU 486 on glucocorticoid and cytokine responses to Escherichia coli endotoxinA S Hawes, C S Rock, C V Keogh, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1992
Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivoK J Van Zee, T Kohno, E Fischer, et al.
The American Journal of Physiology|March 1, 1992
Insulin-like growth factor I preserves host lean tissue mass in cancer cachexiaE H Ng, C S Rock, D D Lazarus, et al.
The Journal of Surgical Research|August 1, 1991
Impact of exogenous growth hormone on host preservation and tumor cell-cycle distribution in a rat sarcoma modelE H Ng, C S Rock, D Lazarus, et al.
Annals of Surgery|July 1, 1993
Comparison of peripheral blood leukocyte kinetics after live Escherichia coli, endotoxin, or interleukin-1 alpha administration. Studies using a novel interleukin-1 receptor antagonistA S Hawes, E Fischer, M A Marano, et al.
Surgery|August 1, 1992
Influence of hypercortisolemia on the acute-phase protein response to endotoxin in humansC S Rock, S M Coyle, C V Keogh, et al.
Blood|May 1, 1992
Interleukin-1 receptor antagonist circulates in experimental inflammation and in human diseaseE Fischer, K J Van Zee, M A Marano, et al.
The American Journal of Physiology|August 1, 1991
Comparison between effects of interleukin-1 alpha administration and sublethal endotoxemia in primatesE Fischer, M A Marano, A E Barber, et al.
Pageof 2